122 related articles for article (PubMed ID: 2627109)
1. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
2. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).
Brown DH; Braakhuis BJ; Van Dongen GA; Snow GB
Otolaryngol Head Neck Surg; 1990 Jan; 102(1):20-5. PubMed ID: 2106113
[TBL] [Abstract][Full Text] [Related]
4. The effect of high dose vitamin A on the morphology and proliferative activity of xenograft lung and head and neck cancer.
Mourad WA; Bruner JM; Vallieres E; McName C; Alabdulwahed S; Scott K; Oldring DJ
In Vivo; 1996; 10(3):329-33. PubMed ID: 8797035
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; Clavel M; Kirkpatrick A
Ann Oncol; 1992 Mar; 3(3):223-6. PubMed ID: 1586620
[TBL] [Abstract][Full Text] [Related]
6. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
Kang MH; Harutyunyan N; Hall CP; Papa RA; Lock RB
Br J Haematol; 2009 May; 145(3):389-93. PubMed ID: 19298590
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
9. Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate.
Verweij J; Schornagel J; de Mulder P; Henzen-Logmans S; Cognetti F; Clavel M; Vermorken J
Cancer; 1990 Nov; 66(9):1910-3. PubMed ID: 2224785
[TBL] [Abstract][Full Text] [Related]
10. Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice.
Braakhuis BJ; van Dongen GA; Bagnay M; van Walsum M; Snow GB
Head Neck; 1989; 11(6):511-5. PubMed ID: 2584006
[TBL] [Abstract][Full Text] [Related]
11. 10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor properties.
Sirotnak FM; Schmid FA; Samuels LL; DeGraw JI
NCI Monogr; 1987; (5):127-31. PubMed ID: 2448650
[TBL] [Abstract][Full Text] [Related]
12. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
13. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
14. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
16. A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice.
Sirotnak FM; DeGraw JI; Colwell WT; Piper JR
Cancer Chemother Pharmacol; 1998; 42(4):313-8. PubMed ID: 9744777
[TBL] [Abstract][Full Text] [Related]
17. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Heo DS; Snyderman C; Gollin SM; Pan S; Walker E; Deka R; Barnes EL; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1989 Sep; 49(18):5167-75. PubMed ID: 2766286
[TBL] [Abstract][Full Text] [Related]
18. Antitumor properties of a new folate analog, 10-deaza-aminopterin, in mice.
Sirotnak FM; DeGraw JI; Moccio DM; Dorick DM
Cancer Treat Rep; 1978 Jul; 62(7):1047-52. PubMed ID: 688246
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.
van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ
Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
Sirotnak FM; Donsback RC
Cancer Res; 1975 Jul; 35(7):1737-44. PubMed ID: 1169115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
